Objective The treatment of refractory vasodilatory shock in patients undergoing
extracorporeal membrane oxygenation (ECMO) is an area in which there is minimal
literature. Based on previous literature, the authors hypothesized that at least 40% of ECMO
patients with vasoplegia would respond positively to methylene blue (MB) administration
and that those who responded to MB would have increased survival. Design Retrospective
observational study. Setting Single institution, quaternary care hospital. Participants The …